363 related articles for article (PubMed ID: 12154002)
1. Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity.
Linhart B; Jahn-Schmid B; Verdino P; Keller W; Ebner C; Kraft D; Valenta R
FASEB J; 2002 Aug; 16(10):1301-3. PubMed ID: 12154002
[TBL] [Abstract][Full Text] [Related]
2. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
Focke M; Mahler V; Ball T; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
FASEB J; 2001 Sep; 15(11):2042-4. PubMed ID: 11511525
[TBL] [Abstract][Full Text] [Related]
3. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.
Linhart B; Hartl A; Jahn-Schmid B; Verdino P; Keller W; Krauth MT; Valent P; Horak F; Wiedermann U; Thalhamer J; Ebner C; Kraft D; Valenta R
J Allergy Clin Immunol; 2005 May; 115(5):1010-6. PubMed ID: 15867859
[TBL] [Abstract][Full Text] [Related]
4. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
[TBL] [Abstract][Full Text] [Related]
5. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.
Edlmayr J; Niespodziana K; Linhart B; Focke-Tejkl M; Westritschnig K; Scheiblhofer S; Stoecklinger A; Kneidinger M; Valent P; Campana R; Thalhamer J; Popow-Kraupp T; Valenta R
J Immunol; 2009 May; 182(10):6298-306. PubMed ID: 19414783
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
7. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
8. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
Flicker S; Steinberger P; Ball T; Krauth MT; Verdino P; Valent P; Almo S; Valenta R
J Allergy Clin Immunol; 2006 Jun; 117(6):1336-43. PubMed ID: 16750995
[TBL] [Abstract][Full Text] [Related]
9. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens.
Canis M; Gröger M; Becker S; Klemens C; Kramer MF
Am J Rhinol Allergy; 2011; 25(1):36-9. PubMed ID: 21711974
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
Focke-Tejkl M; Weber M; Niespodziana K; Neubauer A; Huber H; Henning R; Stegfellner G; Maderegger B; Hauer M; Stolz F; Niederberger V; Marth K; Eckl-Dorna J; Weiss R; Thalhamer J; Blatt K; Valent P; Valenta R
J Allergy Clin Immunol; 2015 May; 135(5):1207-7.e1-11. PubMed ID: 25441634
[TBL] [Abstract][Full Text] [Related]
11. Recombinant monoclonal human immunoglobulin E to investigate the allergenic activity of major grass pollen allergen Phl p 5.
Madritsch C; Flicker S; Scheiblhofer S; Zafred D; Pavkov-Keller T; Thalhamer J; Keller W; Valenta R
Clin Exp Allergy; 2011 Feb; 41(2):270-80. PubMed ID: 21143538
[TBL] [Abstract][Full Text] [Related]
12. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
[TBL] [Abstract][Full Text] [Related]
13. Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.
Linhart B; Focke-Tejkl M; Weber M; Narayanan M; Neubauer A; Mayrhofer H; Blatt K; Lupinek C; Valent P; Valenta R
J Immunol; 2015 Apr; 194(8):4008-18. PubMed ID: 25786690
[TBL] [Abstract][Full Text] [Related]
14. Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody.
Flicker S; Steinberger P; Norderhaug L; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
Eur J Immunol; 2002 Aug; 32(8):2156-62. PubMed ID: 12209627
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and immunological characterization of full-length timothy grass pollen allergen Phl p 4, a berberine bridge enzyme-like protein with homology to celery allergen Api g 5.
Dewitt AM; Andersson K; Peltre G; Lidholm J
Clin Exp Allergy; 2006 Jan; 36(1):77-86. PubMed ID: 16393269
[TBL] [Abstract][Full Text] [Related]
16. Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential.
Stumvoll S; Lidholm J; Thunberg R; DeWitt AM; Eibensteiner P; Swoboda I; Bugajska-Schretter A; Spitzauer S; Vangelista L; Kazemi-Shirazi L; Sperr WR; Valent P; Kraft D; Valenta R
Biol Chem; 2002 Sep; 383(9):1383-96. PubMed ID: 12437131
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
[TBL] [Abstract][Full Text] [Related]
18. Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule.
Metz-Favre C; Linhart B; Focke-Tejkl M; Purohit A; de Blay F; Valenta R; Pauli G
J Allergy Clin Immunol; 2007 Aug; 120(2):315-21. PubMed ID: 17512042
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering of pollen allergens for hayfever immunotherapy.
Bhalla PL
Expert Rev Vaccines; 2003 Feb; 2(1):75-84. PubMed ID: 12901599
[TBL] [Abstract][Full Text] [Related]
20. Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein.
Mothes-Luksch N; Stumvoll S; Linhart B; Focke M; Krauth MT; Hauswirth A; Valent P; Verdino P; Pavkov T; Keller W; Grote M; Valenta R
J Immunol; 2008 Oct; 181(7):4864-73. PubMed ID: 18802090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
